Related Experiment Video

Updated: May 26, 2026

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
06:39

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

Allogenic hematopoietic stem cell as curative treatment in myelofibrosis

Wardhana1, E A Datau, Linda W A Rotty

  • 1Department of Internal Medicine, Siloam International Hospitals, Siloam Hospitals Group's CEO Office, Karawaci, Indonesia. wadiswas@yahoo.com

Acta Medica Indonesiana
|December 14, 2011
PubMed

Insights

Myelofibrosis (MF) is a bone marrow disorder causing collagen buildup. Allogeneic hematopoietic stem cell transplantation (HSTC), particularly using umbilical cord blood (UCB), offers a promising curative treatment for MF patients.

Area of Science:

  • Hematology
  • Oncology
  • Stem Cell Biology

Background:

  • Myelofibrosis (MF) is a Philadelphia chromosome-negative myeloproliferative neoplasm.
  • Characterized by bone marrow fibrosis and extramedullary hematopoiesis.
  • Clinical presentation includes anemia, altered white blood cell counts, and platelet abnormalities.

Purpose of the Study:

  • To summarize the characteristics of Myelofibrosis.
  • To discuss current treatment modalities for MF.
  • To highlight the potential of allogeneic hematopoietic stem cell transplantation (HSTC) using umbilical cord blood (UCB) as a curative option.

Main Methods:

  • Review of existing literature on Myelofibrosis.
  • Analysis of clinical and laboratory findings in MF patients.
  • Evaluation of outcomes for HSTC, specifically with UCB grafts.

Main Results:

  • MF involves significant bone marrow collagen deposition and extramedullary hematopoiesis.
  • Conventional treatments offer supportive care, but HSTC is the only curative option.
  • Umbilical cord blood (UCB) is emerging as a viable and promising stem cell source for HSTC in MF.

Conclusions:

  • Myelofibrosis requires comprehensive management strategies.
  • Allogeneic HSTC represents the sole curative approach for MF.
  • Umbilical cord blood (UCB) transplantation shows significant promise for treating MF.

More Related Videos

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice03:40

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice

Published on: December 8, 2023

Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis06:28

Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis

Published on: November 10, 2023

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
Hematopoiesis01:21

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...